Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Revenue growth (%)

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Dec 31, 20255.8+136.89%
Dec 31, 20242.4-48.20%
Dec 31, 20234.7-94.80%
Dec 31, 202290.6-42.83%
Dec 31, 2021158.5+111.56%
Sep 30, 202174.9-1707.30%
Sep 30, 2020-4.7-41.38%
Sep 30, 2019-7.9-185.76%
Sep 30, 20189.3-63.02%
Sep 30, 201725.1-71.32%
Sep 30, 201687.4-7.46%
Sep 30, 201594.5+107.08%
Sep 30, 201445.6+42.88%
Sep 30, 201331.9-11.28%
Sep 30, 201236

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat